AstraZeneca (AZN) News Today $63.20 -0.60 (-0.94%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Berenberg Bank Sticks to Their Buy Rating for AstraZeneca (AZN)November 20 at 9:23 AM | markets.businessinsider.comUBS upgrades AstraZeneca (AZN) to a HoldNovember 20 at 9:01 AM | markets.businessinsider.comHowe & Rusling Inc. Sells 29,784 Shares of AstraZeneca PLC (NASDAQ:AZN)Howe & Rusling Inc. reduced its holdings in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 19.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 119,812 shares of the company's stock after selling 29,784 shares during the quarter. Howe &November 20 at 7:52 AM | marketbeat.comAstraZeneca (NASDAQ:AZN) Upgraded at UBS GroupUBS Group upgraded shares of AstraZeneca from a "sell" rating to a "neutral" rating in a research note on Wednesday.November 20 at 7:50 AM | marketbeat.comAstraZeneca awards $3.5M for projects to improve access to healthcare for patients across the USNovember 20 at 7:30 AM | businesswire.comJennison Associates LLC Sells 2,059,108 Shares of AstraZeneca PLC (NASDAQ:AZN)Jennison Associates LLC decreased its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 12.1% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,964,547 shares of the company'sNovember 20 at 7:17 AM | marketbeat.comLeerink Partnrs Predicts Increased Earnings for AstraZenecaAstraZeneca PLC (NASDAQ:AZN - Free Report) - Analysts at Leerink Partnrs boosted their FY2024 earnings per share estimates for AstraZeneca in a research note issued to investors on Monday, November 18th. Leerink Partnrs analyst A. Berens now forecasts that the company will post earnings per shareNovember 20 at 6:39 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Stock Holdings Boosted by Pathstone Holdings LLCPathstone Holdings LLC raised its position in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 3.5% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 347,234 shares of the company's stock after purchasing an additionalNovember 20 at 5:06 AM | marketbeat.comNew Millennium Group LLC Sells 28,749 Shares of AstraZeneca PLC (NASDAQ:AZN)New Millennium Group LLC lessened its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 95.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,426 shares of the company's stock after selliNovember 19 at 9:47 AM | marketbeat.comProspera Financial Services Inc Boosts Stock Position in AstraZeneca PLC (NASDAQ:AZN)Prospera Financial Services Inc boosted its holdings in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 9.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 103,247 shares of the company's stock aNovember 19 at 7:34 AM | marketbeat.comLeerink Partnrs Cuts Earnings Estimates for AstraZenecaAstraZeneca PLC (NASDAQ:AZN - Free Report) - Leerink Partnrs reduced their FY2025 earnings per share estimates for AstraZeneca in a note issued to investors on Monday, November 18th. Leerink Partnrs analyst A. Berens now expects that the company will earn $5.28 per share for the year, down from tNovember 19 at 6:52 AM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Bought by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. grew its stake in shares of AstraZeneca PLC (NASDAQ:AZN - Free Report) by 13.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 84,511 shares of the compaNovember 19 at 3:49 AM | marketbeat.comLunit announces collaboration with AstraZeneca to develop AI-powered toolsNovember 19 at 2:18 AM | markets.businessinsider.comSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC - AZNNovember 18 at 9:52 PM | prnewswire.comGRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer StudyNovember 18 at 4:01 PM | prnewswire.comLunit Collaborates With AstraZeneca To Develop AI-powered Digital Pathology SolutionsNovember 18 at 3:35 PM | markets.businessinsider.comTD Cowen Remains a Buy on AstraZeneca (AZN)November 18 at 3:35 PM | markets.businessinsider.comIs AstraZeneca PLC (AZN) the Best Immunotherapy Stock to Buy Now?November 18 at 10:32 AM | msn.comAstraZeneca’s Tagrisso recommended for approval in EU by CHMP for certain NSCLCNovember 18 at 10:32 AM | markets.businessinsider.comLunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLCNovember 18 at 9:00 AM | prnewswire.comIs AstraZeneca PLC (AZN) A Cheap NASDAQ Stock To Invest In Now?November 18 at 5:35 AM | finance.yahoo.comIs AstraZeneca PLC (AZN) A Cheap NASDAQ Stock To Invest In Now?November 18 at 5:05 AM | insidermonkey.comNatixis Advisors LLC Boosts Holdings in AstraZeneca PLC (NASDAQ:AZN)Natixis Advisors LLC increased its stake in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 6.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,960,815 shares of the company's stoNovember 16, 2024 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Sees Large Increase in Short InterestAstraZeneca PLC (NASDAQ:AZN - Get Free Report) saw a significant growth in short interest in the month of October. As of October 31st, there was short interest totalling 4,630,000 shares, a growth of 14.9% from the October 15th total of 4,030,000 shares. Based on an average trading volume of 4,910,000 shares, the short-interest ratio is presently 0.9 days.November 16, 2024 | marketbeat.comAstraZeneca Chair Buys Shares, Signals ConfidenceNovember 15, 2024 | markets.businessinsider.comPharma Stock Roundup: AZN, BAYRY's Earnings, ABBV's Pipeline SetbackNovember 15, 2024 | msn.comAstraZeneca CEO’s Share Purchase Signals ConfidenceNovember 15, 2024 | markets.businessinsider.comEuropean And US Vaccine Stocks Are Under Pressure - Here's WHyNovember 15, 2024 | benzinga.comIs AstraZeneca a Buy as It Eyes the Weight Loss Market?November 14, 2024 | fool.comAstraZeneca: Strong Growth Potential And Market Volatility Offer OpportunityNovember 13, 2024 | seekingalpha.comDeutsche Bank Keeps Their Hold Rating on AstraZeneca (AZN)November 13, 2024 | markets.businessinsider.comMQS Management LLC Has $832,000 Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)MQS Management LLC boosted its position in AstraZeneca PLC (NASDAQ:AZN - Free Report) by 303.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 10,681 shares of the company's stock after purchasing an additional 8,033 shares during the period. MQS Management LLCNovember 13, 2024 | marketbeat.comHealthy Returns: AstraZeneca expands U.S. investment plan on confidence in economyNovember 13, 2024 | cnbc.comAstraZeneca Reports Strong Growth in Q3 2024November 13, 2024 | markets.businessinsider.comAstraZeneca PLC (AZN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...November 13, 2024 | finance.yahoo.comAstraZeneca Expands U.S. Investment PlanNovember 12, 2024 | wsj.comAstraZeneca PLC (AZN) Q3 2024 Earnings Call TranscriptNovember 12, 2024 | seekingalpha.comAstraZeneca PLC 2024 Q3 - Results - Earnings Call PresentationNovember 12, 2024 | seekingalpha.comMerck, AstraZeneca report positive data for Koselugo in adultsNovember 12, 2024 | msn.comAstraZeneca (AZN) Gets a Hold from JefferiesNovember 12, 2024 | markets.businessinsider.comAstraZeneca Lifts Outlook, Plans $3.5B US InvestmentNovember 12, 2024 | investopedia.comGoldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN)November 12, 2024 | markets.businessinsider.comUBS Remains a Sell on AstraZeneca (AZN)November 12, 2024 | markets.businessinsider.comAstraZeneca: 450 million pound investment in UK under review amid talks with govtNovember 12, 2024 | reuters.comAstraZeneca’s Strong Growth Spurs 2024 Guidance UpgradeNovember 12, 2024 | markets.businessinsider.comAstraZeneca: 450 million pound investment in UK on hold amid talks with govtNovember 12, 2024 | msn.comHere's Why AstraZeneca (LON:AZN) Has Caught The Eye Of InvestorsNovember 12, 2024 | finance.yahoo.comAstraZeneca Lifts Outlook, Plans $3.5B US InvestmentNovember 12, 2024 | investopedia.comAstraZeneca’s $3.5B US Expansion Fuels Growth AmbitionsNovember 12, 2024 | msn.comAstraZeneca Raises Outlook, Plans U.S. InvestmentNovember 12, 2024 | msn.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼0.580.45▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼3518▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Abbott Laboratories News Merck & Co., Inc. News Pfizer News Bristol-Myers Squibb News AbbVie News Zoetis News Novo Nordisk A/S News Novartis News Sanofi News GSK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AZN Stock Alerts